BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

MediciNova, Inc. 

4350 La Jolla Village Drive, Suite 950

San Diego  California  92122  U.S.A.
Phone: 858-373-1500 Fax: 858-373-7000


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
MediciNova, Inc. Shows Off Positive Phase 2a Study Of Ibudilast 8/19/2014 6:16:00 AM
MediciNova, Inc. Receives Notice Of Allowance For New Patent Covering MN-001 And MN-002 For The Treatment Of Nonalcoholic Fatty Liver Disease 8/11/2014 5:23:23 PM
MediciNova, Inc. Announces Positive Results Of MN-001 In Advanced NASH Mouse Model; Medicinova Requests A Meeting With FDA 8/5/2014 8:29:19 AM
MediciNova, Inc. To Present Data On MN-001 For The Treatment Of NASH (Nonalcoholic Steatohepatitis) During The JDDW 2014 (Japan Digestive Disease Week 2014) 7/8/2014 6:16:41 AM
MediciNova, Inc. Announces Positive Results In Study Of MN-001 In Mouse Model Of Pulmonary Fibrosis 6/12/2014 7:57:10 AM
MediciNova, Inc. Announces Management Appointment 4/9/2014 8:51:00 AM
MediciNova, Inc. Announces Positive Results In NASH Mouse Model With MN-001 And Prepares To Initiate Phase 2 Trial In The U.S. 1/14/2014 9:09:38 AM
MediciNova, Inc. Receives New Patent Covering MN-221 In Irritable Bowel Syndrome 11/12/2013 12:45:02 PM
MediciNova, Inc. Reports Third Quarter 2013 Results 11/8/2013 9:10:11 AM
MediciNova, Inc. Appoints Geoffrey O'Brien as Vice President 10/17/2013 9:35:31 AM
12345678910...